It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The bacterial composition of the gut lumen and mucosa is distinct and the mucosa-associated bacteria are thought to play a more critical role in interactions with the host immune system. However, limited studies of the gut mucosal microbiota in humans have been available due to methodological challenges. Here, we evaluated the potential use of colonic lavage samples for mucosal microbiota analysis in humans. Among the different types of colonic mucosal samples collected from healthy volunteers, the lavage samples contained a higher amount of bacterial DNA and were less contaminated with host DNA compared to mucosal brushing (brush) and biopsy. Although 16S gene amplicon sequencing showed that the bacterial composition of the lavage was intermediate between that of feces and biopsy, mucosal bacteria abundant in the biopsy were also enriched in lavage samples. Furthermore, differences in mucosal microbes between non-smokers and smokers were detectable in lavage samples. Our data emphasize that colonic lavage is suitable for analysis of the mucosal microbiota. Given its minimal invasiveness and high bacterial DNA content, the colonic lavage will promote research on the human mucosal microbiota, especially in gastrointestinal disorders.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 RIKEN Center for Integrative Medical Sciences, Laboratory for Intestinal Ecosystem, Kanagawa, Japan (GRID:grid.509459.4) (ISNI:0000 0004 0472 0267)
2 RIKEN Center for Integrative Medical Sciences, Laboratory for Intestinal Ecosystem, Kanagawa, Japan (GRID:grid.509459.4) (ISNI:0000 0004 0472 0267); Chiba University, Department of Gastroenterology, Graduate School of Medicine, Chiba, Japan (GRID:grid.136304.3) (ISNI:0000 0004 0370 1101)
3 Juntendo University Graduate School of Medicine, Department of Microbiota Research, Tokyo, Japan (GRID:grid.258269.2) (ISNI:0000 0004 1762 2738)
4 RIKEN Center for Integrative Medical Sciences, Laboratory for Intestinal Ecosystem, Kanagawa, Japan (GRID:grid.509459.4) (ISNI:0000 0004 0472 0267); Yokohama City University, Immunobiology Laboratory, Graduate School of Medical Life Science, Kanagawa, Japan (GRID:grid.268441.d) (ISNI:0000 0001 1033 6139); Chiba University, Laboratory for Immune Regulation, Graduate School of Medicine, Chiba, Japan (GRID:grid.136304.3) (ISNI:0000 0004 0370 1101)